P | Deferiprone group (n = 9) | Combined group (n = 26) | Deferoxamine group (n = 21) | P | |
---|---|---|---|---|---|
Age (yrs) | 0.358 | 29.7 ± 5.2 | 27.6 ± 5.7 | 32.8 ± 6.5 | 0.005 |
Male (%) | 0.700 | 66.7% | 53.8% | 23.8% | 0.072 |
Chel. starting age (yrs) | 0.918 | 5.0 ± 3.5 | 5.3 ± 5.3 | 6.7 ± 6.0 | 0.504 |
Mean pre-transfusion Hb (g/dl) | 0.180 | 9.9 ± 0.4 | 9.6 ± 0.5 | 9.8 ± 0.6 | 0.217 |
Mean serum ferritin (ng/l) | 0.001 | 1475 ± 2753 | 2135 ± 966 | 1367 ± 988 | <0.0001 |
Global Heart (ms) | 0.112 | 12.8 ± 3.6 | 10.2 ± 4.3 | 14.4 ± 4.3 | 0.002 |
MRI CIC (mg/g dry weight) | 0.096 | 2.20 ± 0.77 | 3.56 ± 2.65 | 1.99 ± 0.90 | 0.002 |
N seg. With T2* < 20 ms | 0.502 | 14.8 ± 1.8 | 15.2 ± 1.7 | 13.0 ± 3.3 | 0.010 |
Mid septum T2* (ms) | 0.194 | 13.3 ± 5.2 | 10.6 ± 5.4 | 14.6 ± 5.0 | 0.012 |
LV EF (%) | 0.466 | 58.9 ± 5.9 | 61.1 ± 8.3 | 59.9 ± 6.8 | 0.583 |
LV EDVI (ml/m2) | 0.749 | 90.2 ± 18.5 | 87.5 ± 22.2 | 89.9 ± 20.5 | 0.712 |
RV EF (%) | 0.023 | 54.9 ± 5.7 | 60.2 ± 5.7 | 60.4 ± 6.0 | 0.927 |
RV EDVI (ml/m2) | 0.737 | 89.3 ± 20.7 | 86.7 ± 19.7 | 86.1 ± 21.3 | 0.926 |
Liver T2* (ms) | 0.011 | 7.5 ± 5.0 | 3.5 ± 3.5 | 8.2 ± 6.4 | 0.005 |
MRI LIC (mg/g dry weight) | 0.018 | 8.4 ± 12.9 | 14.8 ± 11.8 | 6.8 ± 7.0 | 0.003 |